कोशिश गोल्ड - मुक्त

Bio Spectrum - BioSpectrum India July 2025

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

पढ़ना Bio Spectrum केवल एक सदस्यता के साथ 9,500+ अन्य पत्रिकाएँ और समाचार पत्र

कैटलॉग देखें

1 महीना

$14.99

1 वर्ष $149.99

$149.99

$12/month

(OR)

केवल Bio Spectrum की सदस्यता लें

उपहार Bio Spectrum

किसी भी समय रद्द करें.

(कोई प्रतिबद्धता नहीं) ⓘ

यदि आप सदस्यता से खुश नहीं हैं, तो आप पूर्ण धनवापसी के लिए सदस्यता आरंभ तिथि से 7 दिनों के भीतर हमें help@magzter.com पर ईमेल कर सकते हैं। कोई प्रश्न नहीं पूछा जाएगा - वादा! (नोट: एकल अंक खरीद के लिए लागू नहीं)

डिजिटल सदस्यता

त्वरित पहुँच ⓘ

मैगज़टर वेबसाइट, आईओएस, एंड्रॉइड और अमेज़ॅन ऐप पर तुरंत पढ़ना शुरू करने के लिए अभी सदस्यता लें।

सत्यापित सुरक्षित

भुगतान ⓘ

मैगज़्टर एक सत्यापित स्ट्राइप व्यापारी है।

इस अंक में

Advancing Affordable Indigenous IMMUNOTHERAPIES Immunotherapy is transforming modern medicine by offering targeted, effective, and less toxic treatments for cancer, autoimmune disorders, and infectious diseases. As global demand for these therapies grows, India is rapidly positioning itself as a key player in their development and large-scale production. We shall take a deep dive into India’s immunotherapy research pipeline—what’s driving it, what’s holding it back, and whether the country can truly emerge as a global hub for affordable immunotherapy.

Centre opens investor facilitation portal for traditional medicine sector

The Government of India has launched the Ayush Nivesh Saarthi portal, a dedicated, investor-centric digital platform developed by the Ministry of Ayush in collaboration with Invest India.

1 mins

Ayush Ministry launches.portal to address issues of adverse drug reaction

In a landmark step toward strengthening consumer protection and regulatory oversight in the field of traditional medicine, the Union Minister of State (Independent Charge), Ministry of Ayush; and Union Minister of State, Ministry of Health & Family Welfare, Government of India, Prataprao Jadhav, recently launched the AyushSuraksha Portal.

1 mins

India partners with WHO to mainstream Ayush globally

In a landmark development poised to transform the global standing of traditional medicine systems, an agreement has been signed between the Ministry of Ayush and the World Health Organization (WHO).

1 mins

Shivtek Spechemi Industries invests Rs 600 Cr to set up new unit in Gujarat

Leading speciality chemicals manufacturer, Shivtek Spechemi Industries, a flagship company of the Shiva Group of Industries, focusing on innovation, sustainability, and high-quality solutions for pharmaceuticals, agrochemicals, and industrial coatings, has announced the finalisation of a new manufacturing facility near Hazira, spread across 1 million+ square feet.

1 mins

Aster DM Healthcare to inject Rs 480 Cr in new facility in Bengaluru

Aster DM Healthcare, one of the largest integrated healthcare providers in India, has announced the signing of a lease agreement to establish its 4th Multispecialty Hospital in Bengaluru.

1 mins

Agenus and Zydus Lifesciences enter $141 M strategic collaboration for biologics manufacturing in US

US-based Agenus Inc., a leader in immuno-oncology innovation, has signed definitive partnership agreements with Ahmedabad based Zydus Lifesciences, including its subsidiaries/ affiliates, designed to accelerate clinical development, scale global manufacturing, and expand patient access to botensilimab and balstilimab (BOT/BAL).

1 mins

Miltenyi Biotec India and BIRAC sign Lol to advance India's cell and gene therapy ecosystem

In a significant step toward strengthening India's leadership in cutting-edge biotherapeutics, Miltenyi Biotec India and the Biotechnology Industry Research Assistance Council (BIRAC) have signed a strategic Letter of Intent (LOI) at the BIO International Convention 2025.

1 mins

Mapmygenome goes global with acquisition of Microbiome Insights

Hyderabad-based Mapmygenome, an artificial intelligence (AI)driven leader in genomics and personalised health, has announced the strategic acquisition of Microbiome Insights, a global leader in microbial sequencing.

1 mins

Nitika Pharmaceutical strengthens indigenous manufacturing of complex excipients

The Technology Development Board (TDB), Department of Science and Technology (DST), Government of India has extended financial support to Nitika Pharmaceutical Specialties in Nagpur, for their project titled \"Manufacture of Complex Excipients.\"

1 mins

IKP Knowledge Park inks MoU with BITS Pilani Hyderabad to support startups

IKP Knowledge Park had announced the signing of a Memorandum of Understanding (MoU) with BITS Pilani Hyderabad Campus TBI Society (TBIS), a strategic collaboration to strengthen the innovation and technology transfer ecosystem.

1 mins

Qure.ai unveils new AI-powered co-pilot tool for frontline healthcare workers in LMICs

Leveraging its strength in digital health innovation, Mumbai-based startup Qure.ai has launched a new artificial intelligence (AI)-powered co-pilot tool for frontline healthcare workers in resource-constrained geographies.

1 mins

Vgenomics and Dr. Shroff's Eye Hospital jointly develop unique biomarker to detect Keratoconus

Delhi-NCR based biotech startup Vgenomics has entered into a special partnership with Dr. Shroff's Charity Eye Hospital.

1 mins

Novo Nordisk Foundation enters into strategic framework agreement with WHO to advance global health

Novo Nordisk Foundation has entered into a strategic framework agreement with the World Health Organization (WHO) to advance global health.

1 mins

WHO outlines recommendations to protect infants against RSV

The World Health Organization (WHO) has published its first-ever position paper on immunisation products to protect infants against respiratory syncytial virus (RSV) the leading cause of acute lower respiratory infections in children globally.

1 mins

Africa CDC, WHO, and RKI expand unique partnership to strengthen collaborative surveillance

The World Health Organization (WHO), Africa Centres for Disease Control and Prevention (Africa CDC) and the Robert Koch Institute (RKI) have announced the expansion of the successful Health Security Partnership to Strengthen Disease Surveillance in Africa (HSPA) to seven countries on the continent.

1 mins

Advancing Affordable Indigenous IMMUNOTHERAPIES

Immunotherapy is transforming modern medicine by offering targeted, effective, and less toxic treatments for cancer, autoimmune disorders, and infectious diseases. As global demand for these therapies grows, India is rapidly positioning itself as a key player in their development and largescale production. We shall take a deep dive into India’s immunotherapy research pipeline—what's driving it, what's holding it back, and whether the country can truly emerge as a global hub for affordable immunotherapy.

10+ mins

How Immune Cell and Gene Therapies are Transforming Treatment in India.

Immune cell and gene therapies are redefining treatment for cancer, genetic disorders, and autoimmune diseases in India. Once considered the realm of science fiction, these living medicines are now at the forefront of clinical care, offering hope for previously untreatable or poorly managed conditions.

4 mins

India-Japan Synergies in CAR-T and ADCs

Cancer remains the leading cause of death globally. As per the World Health Organisation (WHO), there were approximately 9.7 million deaths from cancer in 2022, and around 20 million cancer cases were reported. It is estimated that by 2050, global cancer cases will be around 50 million globally. The rising incidence of cancer has led to a growing focus on individualised and targeted care.

4 mins

Indian Pharma Exporters Recalibrate Strategies Amid US Drug Price Cuts

US President Donald Trump's recent announcement to cut the cost of prescription drugs has jolted Indian and APAC manufacturers. While this new development comes a few months after the initial pharma tariff move, Indian pharmaceutical companies aren't left with much choice except to strategise their next steps pragmatically. Here we seek some clarity about what stance the Indian manufactures might take to counter such economic bullying tactics of countries like the United States.

8 mins

Can Indian Companies Compete with MNCs in GLP-1 Production?

With the patents for blockbuster diabetes and obesity drugs, particularly Semaglutide set to expire in India in March 2026, it is expected to trigger a major shift in the market. Indian pharmaceutical companies will be able to launch generic versions of these high-demand GLP-1 receptor agonist drugs. This is a pivotal moment in the offering that will democratise access to expensive therapies that has been till now dominated by multinational companies.

9 mins

“There is a huge gap in corporate engagement and government procurement of innovative products within Telangana”

According to the world’s leading real estate consulting firm, CNRE’s latest report, ‘Global Life Sciences Atlas’, Hyderabad has emerged as a prominent global centre of life sciences manufacturing activity in India. This positions Telangana to play a defining role in shaping the next decade of biotech innovation and entrepreneurship. In alignment with this development, Hyderabad-based Atal Incubation Centre (AIC), hosted in one of the premier research institutes, CSIR-Centre for Cellular and Molecular Biology (CCMB), seeks unique schemes and proposals from the government to strengthen biotech entrepreneurship in the state. Dr N. Madhusudhana Rao, Chief Executive Officer, AIC-CCMB, spoke with BioSpectrum India, highlighting the dynamic growth trajectory of the biotech innovation ecosystem in Telangana. Edited excerpts:

4 mins

"We see India not just as a trade partner, but as a strategic collaborator for the US market and beyond"

Ella Woger-Nieves, Chief Executive Officer of Invest Puerto Rico, spoke BioSpectrum India on the sidelines of BIO 2025, offering insights into how Puerto Rico has firmly positioned itself as the leading pharmaceutical exporter in the United States. With $54.3 billion in annual life sciences exports to over 120 countries, the island is leveraging its strategic location, FDA-aligned manufacturing ecosystem, and robust talent base to attract global biopharma investments. In this interaction, Ella Woger-Nieves discusses Puerto Rico’s infrastructure, policy incentives, global outreach including recent engagements in India, and its long-term vision as a hub for next-generation therapeutics. Edited excerpts;

4 mins

How genomic revolution is reshaping healthcare in emerging markets

A new frontier in medicine, powered by genomics, is unfolding across emerging economies, promising to transform healthcare landscapes from Egypt to China. The application of genomics in healthcare offers a multi-pronged approach to improving public health, from proactive prevention to highly targeted treatments. The benefits are vast and interconnected, creating a powerful ecosystem for medical innovation. Let's explore further.

5 mins

Why the New Schedule M Is a Game Changer for Indian Pharma and How the Industry Is Adapting

The Indian pharmaceutical industry stands at a pivotal moment. With the government's notification of the revised Schedule M in January 2024, the sector is undergoing a structural and cultural transformation. The updated regulations, which bring India’s Good Manufacturing Practices (GMP) in line with global standards, are not just compliance mandates, they represent a paradigm shift towards consistent quality, operational excellence, and global competitiveness.

4 mins

IIT-KGP inks MoU with German University to foster academic collaboration

The Indian Institute of Technology Kharagpur (IIT-KGP) has signed a Memorandum of Understanding (MoU) with the Technische Universitat Darmstadt, Germany, to foster collaboration in academic, research and innovation initiatives.

1 mins

Chandigarh University, UP emerges as new hub for pharmacy education in AI and research

Chandigarh University, Uttar Pradesh (UP) Campus, continues to break new ground in AI-augmented multidisciplinary education with a major milestone- its School of Pharmacy has received formal approval from the Pharmacy Council of India (PCI) for its Bachelor of Pharmacy (B.

1 mins

P. D. Hinduja Hospital, King's College London commence first training programme for nurses

P. D. Hinduja Hospital & Medical Research Centre has entered into a strategic services agreement with King's College London, Guy's and St Thomas' NHS Foundation to deliver training in clinical and non-clinical courses for doctors and nurses, research capacity building and executive education to health professionals in India and the UK.

1 mins

IDMA names Nikkhil K Masurkar as Vice Chairperson of R&D and Innovation Committee

Nikkhil K Masurkar, Chief Executive Officer of Mumbai-based Entod Pharmaceuticals, has been appointed Vice Chairperson of the R&D and Innovation Committee of the Indian Drug Manufacturers Association (IDMA) for the 20252026 term.

1 mins

Practo appoints Shoumyan Biswas as Global Chief Strategy & Marketing Officer

Practo, India's largest and most trusted health services platform, has announced the appointment of Shoumyan Biswas as its new Global Chief Strategy & Marketing Officer.

1 mins

Gagandeep Singh Bedi joins Smile Group to lead HealthTech Venture Builder

Smile Group, a technology investor and operator, is launching a Healthtech Venture Builder and has appointed Gagandeep Singh Bedi as Managing Partner to lead the initiative.

1 mins

Sharda Care Healthcity ropes in Dr Chirag Tandon as Director of Internal Medicine

Reinforcing its leadership in comprehensive internal medicine and integrated patient care, Sharda Care Healthcity has appointed renowned physician Dr Chirag Tandon as Director of the Department of Internal Medicine at its state-of-the-art facility in Greater Noida.

1 mins

PAG-led Sekhmet Pharma announces appointment of Santosh Mahil as MD & CEO

A private equity consortium led by PAG, a leading Asia-focused investment firm, has announced the appointment of Santosh Kumar Mahil as the Managing Director (MD) and Chief Executive Officer (CEO) of Sekhmet Pharmaventures, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies.

1 mins

Marengo Asia Hospitals strengthens orthopaedic leadership

Marengo Asia Hospitals' flagship unit, Marengo CIMS Hospital in Ahmedabad, has announced the strengthening of their orthopaedic leadership with the onboarding of world-renowned orthopaedic surgeon Dr K. C. Mehta as Director - Orthopaedics and Joint Replacement, Marengo CIMS Hospital, Ahmedabad.

1 mins

NIT Rourkela designs labelfree biosensor for affordable breast cancer diagnosis

Researchers at the National Institute of Technology (NIT) Rourkela, Odisha have investigated a novel semiconductor devicebased biosensor that can identify breast cancer cells without the need for complicated or expensive laboratory procedures.

1 mins

IIT Madras and US researchers study viruses with potential to kill disease-causing bacteria

Researchers at the Indian Institute of Technology Madras (IIT Madras) and US are studying viruses in freshwater lakes.

1 mins

IISc develops novel nanozyme to prevent excess blood clotting

Researchers at the Indian Institute of Science (IISc), Bengaluru have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood clotting caused by conditions like pulmonary thromboembolism (PTE).

1 mins

VFL Sciences partners with Cytosurge AG to bring FluidFM OMNIUM platform to India

Chennai-based VFL Sciences has entered a partnership with Cytosurge AG to offer the FluidFM OMNIUM platform, a semi-automated single-cell manipulation system for non-destructive injection and extraction, compatible with single-cell RNA analysis and advanced gene editing techniques.

1 mins

Qiagen expands portfolio for minimal residual disease testing in oncology

Netherlands-based holding company Qiagen N.V. has announced the expansion of its oncology diagnostics portfolio with two strategic partnerships to advance the use of minimal residual disease (MRD) testing in clinical trials to support pharma co-development projects for companion diagnostics.

1 mins

Thermo Fisher Scientific launches new Spectral Flow Cytometer

Thermo Fisher Scientific Inc. has launched the spectralenabled Invitrogen Attune Xenith Flow Cytometer, allowing immunology and immuno-oncology researchers to automate and streamline workflows to obtain more detailed and accurate insights from critical cellular samples.

1 mins

Disruptive Al-Driven Innovations in Disease Diagnosis

For years, blood tests have been relied upon for detecting numerous conditions including diabetes, cancer, arthritis, HIV, cardiovascular diseases, genetic disorders, COVID-19 and much more. Joining this list is a first-of-its-kind blood test to detect early onset of Alzheimer’s disease, recently approved by the US Food and Drug Administration.

2 mins

सभी कहानियाँ पढ़ें Bio Spectrum

Bio Spectrum Description:

प्रकाशक: MM-Activ-Sci-Tech-Communication

वर्ग: Business

भाषा: English

आवृत्ति: Monthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.